A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than tha...
Gespeichert in:
| Veröffentlicht in: | Psychopharmacologia 1995-12, Vol.122 (4), p.386-389 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 389 |
|---|---|
| container_issue | 4 |
| container_start_page | 386 |
| container_title | Psychopharmacologia |
| container_volume | 122 |
| creator | BAKER, D. G DIAMOND, B. I VANDER KOLK, B. A KATZ, R GILLETTE, G HAMNER, M KATZELNICK, D KELLER, T MELLMAN, T. A PONTIUS, E ROSENTHAL, M TUCKER, P |
| description | A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD. |
| doi_str_mv | 10.1007/BF02246271 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF02246271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8657838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-8c64c435c1cf54910e2fe870e0c149bbc2ff86577a9068263172548b157ca7b53</originalsourceid><addsrcrecordid>eNpFkL1PwzAQxS0EKqWwsCN5YEIY_JXYGUtFAakSC8yR7dgiKIkr2xnKzB-Oo1blljvd-72T7gFwTfADwVg8Pq0xpbykgpyAOeGMIooFPQVzjBlDjBTyHFzE-I1zcclnYCbLQkgm5-B3CRs_6s4i3bVDcw-DGhrftz82z9tOGas9Mn5IwXfdtOvHLrXI2CHZAGMamx30DurgnQrZN1jYDjB9WZiCVanP3KRvfUwoBTX2KrUm-4KNETZt9KGx4RKcOdVFe3XoC_C5fv5YvaLN-8vbarlBhpUyIWlKbjgrDDGu4BXBljorBbbYEF5pbahz02NCVbiUtGRE0IJLTQphlNAFW4C7_V0TfIzBunob2l6FXU1wPSVZ_yeZ4Zs9vB11b5sjeogu67cHXUWjOpeDM208YrRiJZEV-wNkiXwu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>BAKER, D. G ; DIAMOND, B. I ; VANDER KOLK, B. A ; KATZ, R ; GILLETTE, G ; HAMNER, M ; KATZELNICK, D ; KELLER, T ; MELLMAN, T. A ; PONTIUS, E ; ROSENTHAL, M ; TUCKER, P</creator><creatorcontrib>BAKER, D. G ; DIAMOND, B. I ; VANDER KOLK, B. A ; KATZ, R ; GILLETTE, G ; HAMNER, M ; KATZELNICK, D ; KELLER, T ; MELLMAN, T. A ; PONTIUS, E ; ROSENTHAL, M ; TUCKER, P</creatorcontrib><description>A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/BF02246271</identifier><identifier>PMID: 8657838</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Double-Blind Method ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Monoamine Oxidase Inhibitors - adverse effects ; Monoamine Oxidase Inhibitors - therapeutic use ; Neuropharmacology ; Pharmacology. Drug treatments ; Piperidines - adverse effects ; Piperidines - therapeutic use ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Stress Disorders, Post-Traumatic - drug therapy</subject><ispartof>Psychopharmacologia, 1995-12, Vol.122 (4), p.386-389</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-8c64c435c1cf54910e2fe870e0c149bbc2ff86577a9068263172548b157ca7b53</citedby><cites>FETCH-LOGICAL-c368t-8c64c435c1cf54910e2fe870e0c149bbc2ff86577a9068263172548b157ca7b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2936189$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8657838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BAKER, D. G</creatorcontrib><creatorcontrib>DIAMOND, B. I</creatorcontrib><creatorcontrib>VANDER KOLK, B. A</creatorcontrib><creatorcontrib>KATZ, R</creatorcontrib><creatorcontrib>GILLETTE, G</creatorcontrib><creatorcontrib>HAMNER, M</creatorcontrib><creatorcontrib>KATZELNICK, D</creatorcontrib><creatorcontrib>KELLER, T</creatorcontrib><creatorcontrib>MELLMAN, T. A</creatorcontrib><creatorcontrib>PONTIUS, E</creatorcontrib><creatorcontrib>ROSENTHAL, M</creatorcontrib><creatorcontrib>TUCKER, P</creatorcontrib><title>A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monoamine Oxidase Inhibitors - adverse effects</subject><subject>Monoamine Oxidase Inhibitors - therapeutic use</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - adverse effects</subject><subject>Piperidines - therapeutic use</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Stress Disorders, Post-Traumatic - drug therapy</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkL1PwzAQxS0EKqWwsCN5YEIY_JXYGUtFAakSC8yR7dgiKIkr2xnKzB-Oo1blljvd-72T7gFwTfADwVg8Pq0xpbykgpyAOeGMIooFPQVzjBlDjBTyHFzE-I1zcclnYCbLQkgm5-B3CRs_6s4i3bVDcw-DGhrftz82z9tOGas9Mn5IwXfdtOvHLrXI2CHZAGMamx30DurgnQrZN1jYDjB9WZiCVanP3KRvfUwoBTX2KrUm-4KNETZt9KGx4RKcOdVFe3XoC_C5fv5YvaLN-8vbarlBhpUyIWlKbjgrDDGu4BXBljorBbbYEF5pbahz02NCVbiUtGRE0IJLTQphlNAFW4C7_V0TfIzBunob2l6FXU1wPSVZ_yeZ4Zs9vB11b5sjeogu67cHXUWjOpeDM208YrRiJZEV-wNkiXwu</recordid><startdate>19951201</startdate><enddate>19951201</enddate><creator>BAKER, D. G</creator><creator>DIAMOND, B. I</creator><creator>VANDER KOLK, B. A</creator><creator>KATZ, R</creator><creator>GILLETTE, G</creator><creator>HAMNER, M</creator><creator>KATZELNICK, D</creator><creator>KELLER, T</creator><creator>MELLMAN, T. A</creator><creator>PONTIUS, E</creator><creator>ROSENTHAL, M</creator><creator>TUCKER, P</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19951201</creationdate><title>A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder</title><author>BAKER, D. G ; DIAMOND, B. I ; VANDER KOLK, B. A ; KATZ, R ; GILLETTE, G ; HAMNER, M ; KATZELNICK, D ; KELLER, T ; MELLMAN, T. A ; PONTIUS, E ; ROSENTHAL, M ; TUCKER, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-8c64c435c1cf54910e2fe870e0c149bbc2ff86577a9068263172548b157ca7b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monoamine Oxidase Inhibitors - adverse effects</topic><topic>Monoamine Oxidase Inhibitors - therapeutic use</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - adverse effects</topic><topic>Piperidines - therapeutic use</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Stress Disorders, Post-Traumatic - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BAKER, D. G</creatorcontrib><creatorcontrib>DIAMOND, B. I</creatorcontrib><creatorcontrib>VANDER KOLK, B. A</creatorcontrib><creatorcontrib>KATZ, R</creatorcontrib><creatorcontrib>GILLETTE, G</creatorcontrib><creatorcontrib>HAMNER, M</creatorcontrib><creatorcontrib>KATZELNICK, D</creatorcontrib><creatorcontrib>KELLER, T</creatorcontrib><creatorcontrib>MELLMAN, T. A</creatorcontrib><creatorcontrib>PONTIUS, E</creatorcontrib><creatorcontrib>ROSENTHAL, M</creatorcontrib><creatorcontrib>TUCKER, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BAKER, D. G</au><au>DIAMOND, B. I</au><au>VANDER KOLK, B. A</au><au>KATZ, R</au><au>GILLETTE, G</au><au>HAMNER, M</au><au>KATZELNICK, D</au><au>KELLER, T</au><au>MELLMAN, T. A</au><au>PONTIUS, E</au><au>ROSENTHAL, M</au><au>TUCKER, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1995-12-01</date><risdate>1995</risdate><volume>122</volume><issue>4</issue><spage>386</spage><epage>389</epage><pages>386-389</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>8657838</pmid><doi>10.1007/BF02246271</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-3158 |
| ispartof | Psychopharmacologia, 1995-12, Vol.122 (4), p.386-389 |
| issn | 0033-3158 1432-2072 |
| language | eng |
| recordid | cdi_crossref_primary_10_1007_BF02246271 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adult Aged Biological and medical sciences Double-Blind Method Female Humans Male Medical sciences Middle Aged Monoamine Oxidase Inhibitors - adverse effects Monoamine Oxidase Inhibitors - therapeutic use Neuropharmacology Pharmacology. Drug treatments Piperidines - adverse effects Piperidines - therapeutic use Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Stress Disorders, Post-Traumatic - drug therapy |
| title | A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20double-blind,%20randomized,%20placebo-controlled,%20multi-center%20study%20of%20brofaromine%20in%20the%20treatment%20of%20post-traumatic%20stress%20disorder&rft.jtitle=Psychopharmacologia&rft.au=BAKER,%20D.%20G&rft.date=1995-12-01&rft.volume=122&rft.issue=4&rft.spage=386&rft.epage=389&rft.pages=386-389&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/BF02246271&rft_dat=%3Cpubmed_cross%3E8657838%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8657838&rfr_iscdi=true |